Why BioCryst Shares Plunged
Oct 31st 2012 3:17PM
Updated Oct 31st 2012 3:18PM
Hurricane Sandy may have delayed trading for two days, but within the risky world of small-cap health care stocks, shares of a couple of companies wasted no time making huge moves once trading began.
On the postive end of the spectrum, shares of medical robotics company Hansen Medical (NAS: HNSN) are soaring in response to a cash infusion from its larger peer, Intuitive Surgical (NAS: ISRG) . On the flip side, shares of BioCryst Pharmaceuticals (NAS: BCRX) are tanking after the company pulled an application to begin clinical trials of a potentially lucrative drug.
In the following video, health care bureau chief Brenton Flynn discusses today's huge share price swings in the industry.
While you can certainly make huge gains in biotech and pharmaceuticals, the best investing approach is to choose great companies and stick with them for the long term. In our free report "3 Stocks That Will Help You Retire Rich," we name stocks that could help you build long-term wealth and retire well, along with some winning wealth-building strategies that every investor should be aware of. Click here now to keep reading.
The article Why BioCryst Shares Plunged originally appeared on Fool.com.Brenton Flynn has no positions in the stocks mentioned above. The Motley Fool owns shares of Intuitive Surgical. Motley Fool newsletter services recommend Hansen Medical and Intuitive Surgical. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Copyright © 1995 - 2012 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.